Indical Bioscience Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 69

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

  • Investments
  • 2

Indical Bioscience General Information

Description

Manufacturer of diagnostic products catering to animal and human health. The company develops and markets diagnostic solutions and products based on PCR (molecular) and ELISA (immunodiagnostic) technology which are used by laboratories primarily to indicate and diagnose viruses and bacteria in production animals, to counteract proliferation and contribute to better animal and human health.

Contact Information

Website
www.indical.com
Formerly Known As
LDL, QIAGEN Leipzig GmbH, Laboratory Diagnostics GmbH
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Deutscher Platz 5b
  • 04103 Leipzig
  • Germany
+49 0341
Primary Industry
Other Commercial Products
Parent Company
Vertical(s)
Corporate Office
  • Deutscher Platz 5b
  • 04103 Leipzig
  • Germany
+49 0341

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Indical Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Indical Bioscience‘s full profile, request access.

Request a free trial

Indical Bioscience Patents

Indical Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3126530-A1 Method for specific detection of classical swine fever virus Active 04-Apr-2014
EP-3126530-B1 Method for specific detection of classical swine fever virus Active 04-Apr-2014
ES-2717793-T3 Method for the specific detection of the virus of the classic swine fever Active 04-Apr-2014
EP-2392680-A1 Method for specific detection of classical swine fever virus Inactive 04-Jun-2010
EP-2576841-A1 Method for specific detection of classical swine fever virus Active 04-Jun-2010 C12Q1/70
To view Indical Bioscience’s complete patent history, request access »

Indical Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Indical Bioscience Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Indical Bioscience‘s full profile, request access.

Request a free trial

Indical Bioscience Investments & Acquisitions (2)

Indical Bioscience’s most recent deal was a Buyout/LBO with Check-Points. The deal was made on 23-Aug-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Check-Points 23-Aug-2021 Buyout/LBO Diagnostic Equipment
Svanova 01-Apr-2021 Merger/Acquisition Diagnostic Equipment
To view Indical Bioscience’s complete investments and acquisitions history, request access »

Indical Bioscience Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Check-Points Wageningen, Netherlands 2002
Svanova Uppsala, Sweden 2001

Indical Bioscience FAQs

  • When was Indical Bioscience founded?

    Indical Bioscience was founded in 1996.

  • Where is Indical Bioscience headquartered?

    Indical Bioscience is headquartered in Leipzig, Germany.

  • What is the size of Indical Bioscience?

    Indical Bioscience has 69 total employees.

  • What industry is Indical Bioscience in?

    Indical Bioscience’s primary industry is Other Commercial Products.

  • Is Indical Bioscience a private or public company?

    Indical Bioscience is a Private company.

  • What is Indical Bioscience’s current revenue?

    The current revenue for Indical Bioscience is .

  • Who are Indical Bioscience’s investors?

    Qiagen has invested in Indical Bioscience.

  • When was Indical Bioscience acquired?

    Indical Bioscience was acquired on 05-Apr-2018.

  • Who acquired Indical Bioscience?

    Indical Bioscience was acquired by Fidelio Capital.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process